AI Insight
Thousands of people in China underwent a surgical procedure designed to improve the removal of Alzheimer's-related proteins from the brain before the operation was officially banned by Chinese authorities. The surgery aimed to enhance clearance of amyloid and other pathological proteins associated with Alzheimer's disease through a surgical intervention. The procedure was performed on a large scale before regulatory action was taken to prohibit it.
Why it matters
This case highlights significant concerns about medical oversight and patient safety in experimental treatments for neurodegenerative diseases. It raises important questions about the regulation of unproven surgical interventions and the protection of vulnerable patient populations seeking treatments for conditions with limited therapeutic options.
Understand the Science
Surgery that aims to enhance the clearance of Alzheimer’s-associated proteins from the brain has been banned in China, but only after thousands of people had the procedure
Source: Thousands of people in China have had banned Alzheimer’s surgery